Pages that link to "Q37257534"
Jump to navigation
Jump to search
The following pages link to Pentosidine and increased fracture risk in older adults with type 2 diabetes (Q37257534):
Displaying 50 items.
- Does accumulation of advanced glycation end products contribute to the aging phenotype? (Q24632710) (← links)
- Assessment of bone turnover and bone quality in type 2 diabetic bone disease: current concepts and future directions (Q26750574) (← links)
- Childhood obesity, bone development, and cardiometabolic risk factors (Q26853091) (← links)
- The alliance of mesenchymal stem cells, bone, and diabetes (Q27012497) (← links)
- Advanced Glycation End Products, Diabetes, and Bone Strength (Q28076977) (← links)
- Heterogeneous glycation of cancellous bone and its association with bone quality and fragility (Q28482286) (← links)
- Insulin-like growth factor 1, glycation and bone fragility: implications for fracture resistance of bone (Q28543129) (← links)
- Diabetes, bone and glucose-lowering agents: clinical outcomes (Q30234622) (← links)
- Mechanisms of diabetes mellitus-induced bone fragility (Q30241947) (← links)
- Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes. (Q30249436) (← links)
- Bone structure and turnover in type 2 diabetes mellitus (Q33350839) (← links)
- Diabetes, bone and glucose-lowering agents: basic biology (Q33843692) (← links)
- Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis (Q34161200) (← links)
- Early-onset type 2 diabetes impairs skeletal acquisition in the male TALLYHO/JngJ mouse (Q34185713) (← links)
- Fat infiltration of muscle, diabetes, and clinical fracture risk in older adults (Q34262418) (← links)
- Bone mineralization is elevated and less heterogeneous in adults with type 2 diabetes and osteoarthritis compared to controls with osteoarthritis alone (Q34565606) (← links)
- Changes in trabecular bone microarchitecture in postmenopausal women with and without type 2 diabetes: a two year longitudinal study (Q34636672) (← links)
- Glycation of human cortical and cancellous bone captures differences in the formation of Maillard reaction products between glucose and ribose (Q35101624) (← links)
- Osteoporosis in men with diabetes mellitus (Q35101854) (← links)
- Fracture risk in diabetic elderly men: the MrOS study (Q35130554) (← links)
- Focal therapeutic irradiation induces an early transient increase in bone glycation. (Q35245623) (← links)
- Bone fragility in type 2 diabetes mellitus (Q35825346) (← links)
- Fracture incidence and risk of osteoporosis in female type 2 diabetic patients in Korea (Q35911081) (← links)
- Circulating levels of carboxy‐methyl‐lysine (CML) are associated with hip fracture risk: the Cardiovascular Health Study (Q35911173) (← links)
- Skin advanced glycation end-product accumulation is negatively associated with calcaneal osteo-sono assessment index among non-diabetic adult Japanese men. (Q35963018) (← links)
- The Effects of Bazedoxifene on Bone, Glucose, and Lipid Metabolism in Postmenopausal Women With Type 2 Diabetes: An Exploratory Pilot Study (Q36009691) (← links)
- Determinants of bone strength and quality in diabetes mellitus in humans (Q36373016) (← links)
- Bisphosphonate Treatment in Osteoporosis: Optimal Duration of Therapy and the Incorporation of a Drug Holiday (Q36523054) (← links)
- Type 2 diabetes and bone fractures (Q36580627) (← links)
- Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure (Q36672445) (← links)
- Advanced Glycation End-products and Bone Fractures (Q36868071) (← links)
- Diabetes and change in bone mineral density at the hip, calcaneus, spine, and radius in older women (Q36885771) (← links)
- Nonenzymatic Glycation and Degree of Mineralization Are Higher in Bone From Fractured Patients With Type 1 Diabetes Mellitus. (Q36924625) (← links)
- Low Bone Mass is Associated with Increased Carotid Intima Media Thickness in Men with Type 2 Diabetes Mellitus (Q36929402) (← links)
- Validity of leptin receptor-deficiency (db/db) type 2 diabetes mellitus mice as a model of secondary osteoporosis (Q36990610) (← links)
- Bone metabolism and fracture risk in type 2 diabetes mellitus (Q37056305) (← links)
- Diabetes and fractures: an overshadowed association (Q37102803) (← links)
- Serum and bone pentosidine in patients with low impact hip fractures and in patients with advanced osteoarthritis (Q37119404) (← links)
- Mechanism of action study to evaluate the effect of rosiglitazone on bone in postmenopausal women with type 2 diabetes mellitus: rationale, study design and baseline characteristics (Q37166896) (← links)
- The contribution of collagen crosslinks to bone strength (Q37404948) (← links)
- Bone markers in osteoporosis (Q37590482) (← links)
- Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus (Q37598559) (← links)
- Nanoscale changes in collagen are reflected in physical and mechanical properties of bone at the microscale in diabetic rats. (Q37621815) (← links)
- A review of rodent models of type 2 diabetic skeletal fragility (Q37650212) (← links)
- Urinary biomarkers involved in type 2 diabetes: a review. (Q37707267) (← links)
- Osteoclast Activity and Subtypes as a Function of Physiology and Pathology—Implications for Future Treatments of Osteoporosis (Q37790176) (← links)
- Post-translational modifications of the extracellular matrix are key events in cancer progression: Opportunities for biochemical marker development (Q37867110) (← links)
- Bone, sweet bone--osteoporotic fractures in diabetes mellitus. (Q37976305) (← links)
- The contribution of the extracellular matrix to the fracture resistance of bone (Q38004934) (← links)
- Type 2 diabetes and bone (Q38048186) (← links)